Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000004

Chief Discovery Officer acquired 6,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kreitzer Anatol Chief Discovery Officer 2026-02-05 Grant or award +6,020 259,928 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kreitzer Anatol Chief Discovery Officer 2026-02-05 Grant or award · Employee Stock Option (right to buy) +24,455 24,455 D: show line 2 in the form
Loading xslF345X05/form4-02092026_050207.xml…